Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19 | Zendy

Ahmet Yozgat | Zendy; Benan Kasapoğlu | Zendy; Güray Can | Zendy; Alpaslan Tanoğlu | Zendy; Yusuf Serdar Sakın | Zendy; Kadir Serkan Yalçın | Zendy; Müjgan GÜRLER | Zendy; Mustafa Kaplan | Zendy; Mehmet Göktürk Kaban | Zendy; Mehmet KIRSOY | Zendy; Umut Kara | Zendy; Murat Kekilli | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-term proton pump inhibitor use is a risk factor for mortality in patients hospitalized for COVID-19

Author(s) -

Ahmet Yozgat,

Benan Kasapoğlu,

Güray Can,

Alpaslan Tanoğlu,

Yusuf Serdar Sakın,

Kadir Serkan Yalçın,

Müjgan GÜRLER,

Mustafa Kaplan,

Mehmet Göktürk Kaban,

Mehmet KIRSOY,

Umut Kara,

Murat Kekilli

Publication year - 2021

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2103-80

Subject(s) - medicine , proton pump inhibitor , covid-19 , retrospective cohort study , risk factor , intubation , disease , surgery , infectious disease (medical specialty)

The aim of this study is to evaluate whether the long-term (≥4 weeks) use of proton pump inhibitors (PPIs) is a risk factor for intubation requirement and mortality in patients hospitalized for COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research